GSK Income Statement Analysis

Revenue, earnings, and profit margins in billions GBP

Scroll to see more
GSK plc income statement - Annual data in billions GBP
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue31.9531.3830.3329.3224.7024.3533.7530.82
Cost of Revenue8.779.058.579.558.167.3211.8610.24
Gross Profit23.1822.3321.7619.7716.5317.0321.8920.58
Operating Expenses
Research & Development7.346.403.335.495.024.404.573.89
Selling, General & Administrative8.8211.029.518.377.077.0411.409.92
Operating Expenses16.1716.7914.4213.0411.6610.9815.6013.52
Operating Income7.015.547.646.734.886.056.297.06
Other Income/Expense
Interest Income0.170.060.110.030.010.030.000.07
Interest Expense0.690.64-0.710.830.76-0.840.000.69
Other Income/Expense0.23-0.060.31-0.04-0.01-0.020.000.00
Income
Income Before Tax7.243.486.065.633.605.176.224.80
Income Tax Expense1.090.530.760.710.080.070.950.75
Net Income5.592.584.9314.964.395.754.653.62
Net Income - Continuous Operations5.592.955.314.923.520.000.000.00
Net Income - Discontinued Operations0.000.000.0010.701.580.000.000.00
EBITDA11.626.679.088.606.498.107.107.35
EBIT9.434.126.796.454.366.057.105.49
Depreciation & Amortization3.702.552.252.152.122.050.000.00
Earnings Per Share
Basic EPS3.001.001.007.002.001.001.001.00
Diluted EPS3.001.001.007.002.001.001.001.00
Basic Shares Outstanding2.032.044.052.012.003.983.172.46
Diluted Shares Outstanding2.062.074.112.042.034.033.212.49